Mediastinal follicular dendritic cell sarcoma: a rare, potentially under-recognized, and often misdiagnosed disease

Abstract Background Mediastinal follicular dendritic cell sarcoma (FDCS) is extremely rare. Due to potential under-recognization of this disease, it happens to be misdiagnosed, especially on core needle biopsy. We report 3 cases of mediastinal FDCS and provide a literature review to improve better u...

Full description

Bibliographic Details
Main Authors: You-Li Wu, Feng Wu, Cheng-Ping Xu, Guo-Lei Chen, Yu Zhang, Wei Chen, Xiao-Chu Yan, Guang-Jie Duan
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Diagnostic Pathology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13000-019-0779-3
_version_ 1818963190047834112
author You-Li Wu
Feng Wu
Cheng-Ping Xu
Guo-Lei Chen
Yu Zhang
Wei Chen
Xiao-Chu Yan
Guang-Jie Duan
author_facet You-Li Wu
Feng Wu
Cheng-Ping Xu
Guo-Lei Chen
Yu Zhang
Wei Chen
Xiao-Chu Yan
Guang-Jie Duan
author_sort You-Li Wu
collection DOAJ
description Abstract Background Mediastinal follicular dendritic cell sarcoma (FDCS) is extremely rare. Due to potential under-recognization of this disease, it happens to be misdiagnosed, especially on core needle biopsy. We report 3 cases of mediastinal FDCS and provide a literature review to improve better understanding of the tumor and to reduce misdiagnosis. Methods Three cases of mediastinal FDCS in our clinic practice were studied, including their core needle biopsy and resected specimens, and those cases reported previously in English literature were retrieved and analyzed. Results The core needle biopsy of case 1 showed a tumor reminiscent of classical Hodgkin’s lymphoma (CHL), while the resected mass was finally diagnosed with FDCS combined with hyaline-vascular Castleman’s disease. Both the biopsy and resected tissue of case 2 were constitutive of the clear epithelioid cells with marked atypia. In both cases, definitive diagnoses were not made on core needle biopsy. In case 3, there were some areas morphologically similar to CHL, and some areas contained ovoid to spindle-shaped tumor cells with fascicular pattern. The analysis of 43 cases of mediastinal FDCS showed the age of patients were from 16 to 76 years old, the male to female ratio was 1.5:1, the maximal tumor diameters were 3–17 cm. 18 cases were underwent preoperative biopsy, whereas 15 (83.3%) of which were misdiagnosed initially, often as lymphoma. 32 patients had available follow-up data, the rates of recurrence, metastasis, and mortality were 12.5, 18.8 and 28.1%, respectively. Current limited data suggested no statistical differences between adverse prognosis and gender, age, tumor size, necrosis, or different therapeutics, respectively. Conclusions Mediastinal FDCS is a rare malignancy that has yet not been fully understood and been often misdiagnosed, particularly when making a diagnosis on core needle biopsy. Increased awareness of this enigmatic tumor is crucial to avoid diagnostic pitfalls.
first_indexed 2024-12-20T12:41:16Z
format Article
id doaj.art-4cda11d7242343088b6338b61d37d260
institution Directory Open Access Journal
issn 1746-1596
language English
last_indexed 2024-12-20T12:41:16Z
publishDate 2019-01-01
publisher BMC
record_format Article
series Diagnostic Pathology
spelling doaj.art-4cda11d7242343088b6338b61d37d2602022-12-21T19:40:28ZengBMCDiagnostic Pathology1746-15962019-01-0114111110.1186/s13000-019-0779-3Mediastinal follicular dendritic cell sarcoma: a rare, potentially under-recognized, and often misdiagnosed diseaseYou-Li Wu0Feng Wu1Cheng-Ping Xu2Guo-Lei Chen3Yu Zhang4Wei Chen5Xiao-Chu Yan6Guang-Jie Duan7Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University)Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University)Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University)Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University)Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University)Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University)Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University)Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University)Abstract Background Mediastinal follicular dendritic cell sarcoma (FDCS) is extremely rare. Due to potential under-recognization of this disease, it happens to be misdiagnosed, especially on core needle biopsy. We report 3 cases of mediastinal FDCS and provide a literature review to improve better understanding of the tumor and to reduce misdiagnosis. Methods Three cases of mediastinal FDCS in our clinic practice were studied, including their core needle biopsy and resected specimens, and those cases reported previously in English literature were retrieved and analyzed. Results The core needle biopsy of case 1 showed a tumor reminiscent of classical Hodgkin’s lymphoma (CHL), while the resected mass was finally diagnosed with FDCS combined with hyaline-vascular Castleman’s disease. Both the biopsy and resected tissue of case 2 were constitutive of the clear epithelioid cells with marked atypia. In both cases, definitive diagnoses were not made on core needle biopsy. In case 3, there were some areas morphologically similar to CHL, and some areas contained ovoid to spindle-shaped tumor cells with fascicular pattern. The analysis of 43 cases of mediastinal FDCS showed the age of patients were from 16 to 76 years old, the male to female ratio was 1.5:1, the maximal tumor diameters were 3–17 cm. 18 cases were underwent preoperative biopsy, whereas 15 (83.3%) of which were misdiagnosed initially, often as lymphoma. 32 patients had available follow-up data, the rates of recurrence, metastasis, and mortality were 12.5, 18.8 and 28.1%, respectively. Current limited data suggested no statistical differences between adverse prognosis and gender, age, tumor size, necrosis, or different therapeutics, respectively. Conclusions Mediastinal FDCS is a rare malignancy that has yet not been fully understood and been often misdiagnosed, particularly when making a diagnosis on core needle biopsy. Increased awareness of this enigmatic tumor is crucial to avoid diagnostic pitfalls.http://link.springer.com/article/10.1186/s13000-019-0779-3Follicular dendritic cell sarcomaMediastinumRadiologyPathological diagnosisPrognosis
spellingShingle You-Li Wu
Feng Wu
Cheng-Ping Xu
Guo-Lei Chen
Yu Zhang
Wei Chen
Xiao-Chu Yan
Guang-Jie Duan
Mediastinal follicular dendritic cell sarcoma: a rare, potentially under-recognized, and often misdiagnosed disease
Diagnostic Pathology
Follicular dendritic cell sarcoma
Mediastinum
Radiology
Pathological diagnosis
Prognosis
title Mediastinal follicular dendritic cell sarcoma: a rare, potentially under-recognized, and often misdiagnosed disease
title_full Mediastinal follicular dendritic cell sarcoma: a rare, potentially under-recognized, and often misdiagnosed disease
title_fullStr Mediastinal follicular dendritic cell sarcoma: a rare, potentially under-recognized, and often misdiagnosed disease
title_full_unstemmed Mediastinal follicular dendritic cell sarcoma: a rare, potentially under-recognized, and often misdiagnosed disease
title_short Mediastinal follicular dendritic cell sarcoma: a rare, potentially under-recognized, and often misdiagnosed disease
title_sort mediastinal follicular dendritic cell sarcoma a rare potentially under recognized and often misdiagnosed disease
topic Follicular dendritic cell sarcoma
Mediastinum
Radiology
Pathological diagnosis
Prognosis
url http://link.springer.com/article/10.1186/s13000-019-0779-3
work_keys_str_mv AT youliwu mediastinalfolliculardendriticcellsarcomaararepotentiallyunderrecognizedandoftenmisdiagnoseddisease
AT fengwu mediastinalfolliculardendriticcellsarcomaararepotentiallyunderrecognizedandoftenmisdiagnoseddisease
AT chengpingxu mediastinalfolliculardendriticcellsarcomaararepotentiallyunderrecognizedandoftenmisdiagnoseddisease
AT guoleichen mediastinalfolliculardendriticcellsarcomaararepotentiallyunderrecognizedandoftenmisdiagnoseddisease
AT yuzhang mediastinalfolliculardendriticcellsarcomaararepotentiallyunderrecognizedandoftenmisdiagnoseddisease
AT weichen mediastinalfolliculardendriticcellsarcomaararepotentiallyunderrecognizedandoftenmisdiagnoseddisease
AT xiaochuyan mediastinalfolliculardendriticcellsarcomaararepotentiallyunderrecognizedandoftenmisdiagnoseddisease
AT guangjieduan mediastinalfolliculardendriticcellsarcomaararepotentiallyunderrecognizedandoftenmisdiagnoseddisease